Immunology

Tackling allergies through collaborative research and education

The EU-funded Global Allergy and Asthma European Network (GA2LEN), launched in 2004, has become a leading force in the battle against allergic diseases. The network is still expanding, with over 60 centres in more than 20 ...

Medications

AstraZeneca buys US cancer drugs firm

AstraZeneca said on Tuesday that it has agreed to buy US-based cancer drugs company Amplimmune, as the Anglo-Swedish pharmaceuticals group seeks to bolster its flagging pipeline of new products.

Genetics

EU releases 144 mn euro for new rare disease research

The European Union on Thursday pledged 144 million euros of fresh funding for research on rare diseases that currently affect some 30 million Europeans, the majority of them children.

Immunology

Nanotechnology against pollen allergy

Scientists at the Charité – Universitätsmedizin Berlin have now been able to identify the grass pollen molecule, against which the allergic response of hay fever in children is initiated. In addition, it was shown that ...

Arthritis & Rheumatism

Using antibodies against immune deficiency

Early, intensive therapy with a biotechnologically produced medication can provide significantly faster pain relief for patients with rheumatic joint inflammation. Damage to joints can also be reduced when the medication ...

page 23 from 29